MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    The effects of one session of dry needling on vital capacity in people with Parkinson’s Disease

    A. Tahara, A. Gastaldi, A. Chinaglia, R. Monteiro, V. Tumas, P. Santiago (Ribeirão preto, Brazil)

    Objective: The present study aimed to explore the effects of a single session of bilateral DN to the trapezius muscles trigger points on chest expansion and…
  • 2023 International Congress

    Tremor characteristics differentially respond to levodopa and subthalamic nucleus deep brain stimulation in Parkinson’s disease

    T. Wirth, F. Ferreira, N. Vijiaratnam, C. Girges, A. Pakzad, A. Roquemaurel, O. Sinani, J. Hyam, M. Hariz, L. Zrinzo, H. Akram, P. Limousin, T. Foltynie (Strasbourg, France)

    Objective: To identify factors predictive of responsiveness of tremor to levodopa and STN-DBS. Background: Tremor in Parkinson’s disease (PD) is phenotypically variable and has an…
  • 2023 International Congress

    A cross-sectional study of telemedicine use during the COVID-19 pandemic in people with Parkinson’s disease

    A. Patel, R. Schuldt, D. Boudreau, N. Win, B. Cobb, M. Mcginley (South San Francisco, USA)

    Objective: To evaluate telemedicine (TM) use and access patterns during the COVID-19 pandemic in people with Parkinson’s disease (pwPD). Background: pwPD may experience difficulty accessing…
  • 2023 International Congress

    MDS-UPDRS III Off Severity Level changes as a marker of DBS response

    S. Castillo-Torres, I. Cruz, M. Rossi, M. Wilken, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the change in MDS-UPDRS III severity level after Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) in patients with Parkinson’s disease (PD) and evaluate…
  • 2023 International Congress

    Pharmacokinetics, Safety and Tolerability of Foslevodopa/Foscarbidopa Following Continuous Subcutaneous Infusion to Arm, Thigh and Flank compared to Abdomen in Parkinson’s Disease Patients

    Y. Han, H. Kalluri, A. Jeong, C. Locke, M. Facheris, S. Gupta, M. Rosebraugh (North Chicago, USA)

    Objective: To characterize safety/tolerability and pharmacokinetics (PK) of levodopa (LD) and carbidopa (CD) after delivery of foslevodopa/foscarbidopa in Parkinson’s disease (PD) patients at 4 different…
  • 2023 International Congress

    Sleep disorders in Parkinson’s disease patients. A case-control study.

    L. Rotaru, M. Cebuc, A. Lupușor, O. Grosu, S. Odobescu, O. Gavriliuc, I. Moldovanu (Chisinau, Republic of Moldova)

    Objective: To determine the quality of sleep, the type of sleep disorders and their correlations with motor impairment in Parkinson's disease (PD) patients. Background: Sleep…
  • 2023 International Congress

    Social and gender inequity on overall survival and access to deep brain stimulation in Parkinson disease patients in Colombia

    C. Pantoja-Ruiz, D. Rosselli (Bogota, Colombia)

    Objective: Describe discrepancies on survival and access to DBS in PD in Colombia by gender and affiliation regime. Background: Lower socioeconomic status (SES) has been…
  • 2023 International Congress

    Beta LFP Power Change After Levodopa Intake in Parkinson’s Disease Patients with Chronic Sensing-Enabled DBS Systems

    M. de Neeling, M. Stam, B. van Wijk, J. Anso, R. Raike, P. Schuurman, R. de Bie, A. Buijink, M. Beudel (Amsterdam, Netherlands)

    Objective: To study the relationship between oscillatory beta activity in the subthalamic nucleus (STN) and the intake of dopaminergic medication in a group of Parkinson’s…
  • 2023 International Congress

    Response to Levodopa in Parkinson´s Disease Over Time. A 4-year Follow-up Study.

    D. Santos García, T. de Deus, C. Cores, M. Feal Painceiras, I. García-Díaz, M. íñiguez, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, F. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, M. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

    Objective: The aim of the present study was to analyze the response to levodopa in Parkinson´s disease (PD) patients with motor fluctuations followed up for…
  • 2023 International Congress

    Use of the Dysphagia Handicap Index (DHI) patient reported outcomes measure in Parkinson disease and cervical dystonia

    A. Silbergleit (Birmingham, USA)

    Objective: Objective: To demonstrate the value of using the DHI in movement disorders clinics. Background: Background: Dysphagia has a negative effect on work, leisure, and…
  • « Previous Page
  • 1
  • …
  • 233
  • 234
  • 235
  • 236
  • 237
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley